Cui Cui
Stock Analyst at Jefferies
(4.53)
# 1,063
Out of 5,133 analysts
35
Total ratings
60.6%
Success rate
32.3%
Average return
Main Sectors:
Stocks Rated by Cui Cui
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 2269 WuXi Biologics (Cayman) Inc. | Reiterated: Buy | $45.00 → $60.00 | $47.20 | +27.12% | 2 | Aug 27, 2026 | |
| HKG: 1548 Genscript Biotech Corporation | Reiterated: Buy | $15.50 → $30.00 | $30.66 | -2.15% | 2 | Aug 20, 2026 | |
| HKG: 6618 JD Health International Inc. | Reiterated: Buy | $88.00 → $80.00 | $41.48 | +92.86% | 4 | Aug 17, 2026 | |
| HKG: 0241 Alibaba Health Information Technology Limited | Reiterated: Buy | $8.00 → $5.30 | $2.90 | +82.76% | 2 | May 19, 2026 | |
| HKG: 9966 Alphamab Oncology | Reiterated: Buy | $9.60 | $5.84 | +64.52% | 1 | Mar 27, 2026 | |
| HKG: 1833 Ping An Healthcare and Technology Company Limited | Reiterated: Hold | $12.40 | $5.46 | +127.31% | 1 | Mar 25, 2026 | |
| HKG: 9926 Akeso, Inc. | Reiterated: Buy | $226.00 | $83.00 | n/a | 3 | Oct 19, 2025 | |
| HKG: 9606 Duality Biotherapeutics, Inc. | Reiterated: Buy | $500.00 | $103.60 | n/a | 2 | Oct 8, 2025 | |
| HKG: 6990 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Reiterated: Buy | $300.00 → $520.00 | $449.60 | n/a | 3 | Aug 19, 2025 | |
| HKG: 1093 CSPC Pharmaceutical Group Limited | Reiterated: Sell | $5.00 | $8.16 | n/a | 1 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41.00 → $60.00 | $70.10 | n/a | 2 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175.00 → $87.40 | $193.00 | n/a | 2 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40.00 | $85.60 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4.00 | $2.33 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10.80 | $5.86 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26.00 | $16.63 | n/a | 1 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110.00 | $37.16 | n/a | 1 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40.00 → $35.20 | $24.84 | n/a | 2 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28.00 → $25.00 | $34.74 | n/a | 2 | Sep 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10.00 | $14.52 | n/a | 1 | Apr 22, 2020 |
WuXi Biologics (Cayman) Inc.
Aug 27, 2026
Reiterated: Buy
Price Target: $45.00 → $60.00
Current: $47.20
Upside: +27.12%
Genscript Biotech Corporation
Aug 20, 2026
Reiterated: Buy
Price Target: $15.50 → $30.00
Current: $30.66
Upside: -2.15%
JD Health International Inc.
Aug 17, 2026
Reiterated: Buy
Price Target: $88.00 → $80.00
Current: $41.48
Upside: +92.86%
Alibaba Health Information Technology Limited
May 19, 2026
Reiterated: Buy
Price Target: $8.00 → $5.30
Current: $2.90
Upside: +82.76%
Alphamab Oncology
Mar 27, 2026
Reiterated: Buy
Price Target: $9.60
Current: $5.84
Upside: +64.52%
Ping An Healthcare and Technology Company Limited
Mar 25, 2026
Reiterated: Hold
Price Target: $12.40
Current: $5.46
Upside: +127.31%
Akeso, Inc.
Oct 19, 2025
Reiterated: Buy
Price Target: $226.00
Current: $83.00
Upside: n/a
Duality Biotherapeutics, Inc.
Oct 8, 2025
Reiterated: Buy
Price Target: $500.00
Current: $103.60
Upside: n/a
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Aug 19, 2025
Reiterated: Buy
Price Target: $300.00 → $520.00
Current: $449.60
Upside: n/a
CSPC Pharmaceutical Group Limited
Jul 30, 2025
Reiterated: Sell
Price Target: $5.00
Current: $8.16
Upside: n/a
Mar 27, 2025
Reiterated: Buy
Price Target: $41.00 → $60.00
Current: $70.10
Upside: n/a
Mar 21, 2025
Reiterated: Buy
Price Target: $175.00 → $87.40
Current: $193.00
Upside: n/a
Jan 22, 2025
Reiterated: Buy
Price Target: $40.00
Current: $85.60
Upside: n/a
Jan 22, 2025
Reiterated: Buy
Price Target: $4.00
Current: $2.33
Upside: n/a
Jan 22, 2025
Reiterated: Buy
Price Target: $10.80
Current: $5.86
Upside: n/a
Nov 3, 2023
Reiterated: Buy
Price Target: $26.00
Current: $16.63
Upside: n/a
Oct 31, 2023
Reiterated: Buy
Price Target: $110.00
Current: $37.16
Upside: n/a
Oct 27, 2023
Reiterated: Buy
Price Target: $40.00 → $35.20
Current: $24.84
Upside: n/a
Sep 4, 2023
Reiterated: Buy
Price Target: $28.00 → $25.00
Current: $34.74
Upside: n/a
Apr 22, 2020
Downgraded: Hold
Price Target: $10.00
Current: $14.52
Upside: n/a